Abstract:<p>Eomesodermin (Eomes) is a T‐box transcription factors that drive the differentiation and function of cytotoxic lymphocytes. However, the underlying function and mechanism of Eomes in tumor cells remains elusive. Here, we studied the role of Eomes in human esophageal squamous cell carcinoma (ESCC). Using two human ESCC cell lines, we found that Eomes knockdown reduced esophageal cancer cell proliferation, and the esophageal cancer cell cycle is blocked in the G2/M phase. Mechanistically, we identified CCL20 as the main downstream target of Eomes. Furthemore, we found that CCL20 can chemoregulate regulatory T Cells (Tregs) through its specific receptor CCR6 then promote the proliferation of esophageal cancer cells. Eomes knockdown also delayed the growth of human ESCC xenografts in BALB/c nude mice. Importantly, in a total of 133 human ESCC tissues, high Eomes levels were associated with poor clinical prognosis. Overall, our findings suggest that the Eomes‐CCL20‐CCR6 pathway plays a vital role in human ESCC progress. Therefore, targeting this pathway may represent a promising strategy for controlling human ESCC.</p>

Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20‐CCR6 pathway